Stay updated on Pembrolizumab & Lanreotide for GI NETs Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab & Lanreotide for GI NETs Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab & Lanreotide for GI NETs Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    Change Detected
    Summary
    Site revision history shows an addition of v3.5.0 and deletion of v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-19T08:53:12.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3 on the page.
    Difference
    0.1%
    Check dated 2026-03-12T04:29:36.000Z thumbnail image
  5. Check
    55 days ago
    Change Detected
    Summary
    Revision: v3.4.2 is added, replacing earlier revisions. The funding-lapse notice and Revision v3.4.1 have been removed.
    Difference
    0.4%
    Check dated 2026-02-11T17:09:18.000Z thumbnail image
  6. Check
    62 days ago
    Change Detected
    Summary
    Added a site-wide notice about possible delays due to funding, and updated the page revision to v3.4.1. The previous revision was v3.4.0.
    Difference
    0.4%
    Check dated 2026-02-04T10:48:13.000Z thumbnail image
  7. Check
    69 days ago
    Change Detected
    Summary
    UI updates include a new 'Show glossary' option and minor text changes such as capitalization of labels and an updated revision/version to v3.4.0. No substantive study content, outcomes, or eligibility details were altered.
    Difference
    0.2%
    Check dated 2026-01-28T06:38:50.000Z thumbnail image
  8. Check
    83 days ago
    Change Detected
    Summary
    The page shows an administrative revision label: v3.3.4, replacing the previous v3.3.3. No core study content, eligibility criteria, locations, or outcomes were changed.
    Difference
    0.1%
    Check dated 2026-01-14T03:27:18.000Z thumbnail image

Stay in the know with updates to Pembrolizumab & Lanreotide for GI NETs Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab & Lanreotide for GI NETs Clinical Trial page.